Status:
COMPLETED
Comparing Intravenous and Intramuscular Magnesium Sulphate for Preventing Seizure Recurrence in Women With Eclampsia
Lead Sponsor:
Nishtar Medical University
Conditions:
Eclampsia
Seizures
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
The goal of this clinical study is to learn whether the way we give magnesium sulphate-into a vein (intravenous, IV) versus into a muscle (intramuscular, IM)-affects how often women with eclampsia hav...
Eligibility Criteria
Inclusion
- Admitted in labor room due to eclampsia (new onset of grand mal seizure activity and/or unexplained coma during pregnancy)
Exclusion
- Patients with intracranial bleeding (on CT-scan)
- Already received MgSO4, phenytoin and diazepam before attending the hospital
Key Trial Info
Start Date :
May 13 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 12 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06997575
Start Date
May 13 2025
End Date
November 12 2025
Last Update
December 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nishtar Medical University & Hospital
Multan, Punjab Province, Pakistan, 60000